Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma
- PMID: 8988747
- DOI: 10.1002/(sici)1097-0142(19970101)79:1<190::aid-cncr32>3.0.co;2-y
Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma
Comment on
-
Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma.Cancer. 1996 Jun 15;77(12):2574-80. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.0.CO;2-O. Cancer. 1996. PMID: 8640708 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical